Reviva Pharmaceuticals
RVPH
RVPH
22 hedge funds and large institutions have $5.76M invested in Reviva Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
9
Closed
5
Calls
$1.27M
Puts
$821K
Net Calls
+$448K
Net Calls Change
-$312K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$450K |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$390K |
| 3 |
Millennium Management
New York
|
+$161K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$122K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$26.6K |
Top Sellers
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$249K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$164K |
| 3 |
Two Sigma Investments
New York
|
-$128K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$77.2K |
| 5 |
Goldman Sachs
New York
|
-$71.2K |
